The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene
Open accessAbstract
Adenoviral (Ad)-mediated in vivo gene transfer and expression are limited in part by cellular immune responses to viral-encoded proteins and/or transgene immunogenicity. In an attempt to diminish the former responses, we have previously developed and described helper-dependent (HD) Ad vectors in which the viral protein coding sequences are completely eliminated. These HD vectors have up to 37 kb insert capacity, are easily propagated in a Cre recombinase-based system, and can be produced to high concentration and purity (>99.9% helper-free vector). In this study, we compared safety and efficacy of leptin gene delivery mediated by an HD vector (HD-leptin) and a first-generation E1-deleted Ad vector (Ad-leptin) in normal lean and ob/ob (leptin-deficient) mice. In contrast to evidence of liver toxicity, inflammation, and cellular infiltration observed with Ad-leptin delivery in mice, HD-leptin delivery was associated with a significant improvement in associated safety/toxicity and resulted in efficient gene delivery, prolonged elevation of serum leptin levels, and associated weight loss. The greater safety, efficient gene delivery, and increased insert capacity of HD vectors are significant improvements over current Ad vectors and represent favorable features especially for clinical gene therapy applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular Cloning. A Laboratory Manual
Wood, E. (1983) · Biochemical Education · doi:10.1016/0307-4412(83)90068-7 · Cited by 29,533
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Self-citationWeight-Reducing Effects of the Plasma Protein Encoded by the obese Gene
Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451
Effects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Yang, Y., Li, Q., Ertl, H. C., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,032
Construction of adenovirus vectors through Cre-lox recombination
Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., & Phipps, M. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1842-1849.1997 · Cited by 789
Manipulation of Adenovirus Vectors
Graham, F. L., & Prevec, L. (2003) · Gene Transfer and Expression Protocols · doi:10.1385/0-89603-178-0:109 · Cited by 752
Self-citationParks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A., & Graham, F. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13565 · Cited by 725
Self-citationSchiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L., & Kochanek, S. (1998) · Nature Genetics · doi:10.1038/ng0298-180 · Cited by 648
Self-citationTripathy, S. K., Black, H. B., Goldwasser, E., & Leiden, J. M. (1996) · Nature Medicine · doi:10.1038/nm0596-545 · Cited by 628
Kochanek, S., Clemens, P. R., Mitani, K., Chen, H. H., Chan, S., & Caskey, C. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5731 · Cited by 562
Self-citationHerz, J., & Gerard, R. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2812 · Cited by 517
Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 491
Stratford-Perricaudet, L. D., Levrero, M., Chasse, J.-F., Perricaudet, M., & Briand, P. (1990) · Human Gene Therapy · doi:10.1089/hum.1990.1.3-241 · Cited by 325
Persistence in muscle of an adenoviral vector that lacks all viral genes
Chen, H.-H., Mack, L. M., Kelly, R., Ontell, M., Kochanek, S., & Clemens, P. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1645 · Cited by 291
Self-citationRecombinant Adenovirus Deleted of All Viral Genes for Gene Therapy of Cystic Fibrosis
FISHER, K. J., CHOI, H., BURDA, J., CHEN, S.-J., & WILSON, J. M. (1996) · Virology · doi:10.1006/viro.1996.0088 · Cited by 291
Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector.
Mitani, K., Graham, F. L., Caskey, C. T., & Kochanek, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3854 · Cited by 242
Self-citationLieber, A., He, C. Y., Kirillova, I., & Kay, M. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8944-8960.1996 · Cited by 211
Parks, R. J., & Graham, F. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3293-3298.1997 · Cited by 199
Self-citationEngelhardt, J. F., Simon, R. H., Yang, Y., Zepeda, M., Weber-Pendleton, S., Doranz, B., Grossman, M., & Wilson, J. M. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-759 · Cited by 195
Kumar-Singh, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.913 · Cited by 175
Kay, M. A., Li, Q., Liu, T.-J., Leland, F., Toman, C., Finegold, M., & Woo, S. L. C. (1992) · Human Gene Therapy · doi:10.1089/hum.1992.3.6-641 · Cited by 170
Correction of obesity and diabetes in genetically obese mice by leptin gene therapy
Muzzin, P., Eisensmith, R. C., Copeland, K. C., & Woo, S. L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14804 · Cited by 158
Haecker, S. E., Stedman, H. H., Balice‐Gordon, R. J., Smith, D. B. J., Greelish, J. P., Mitchell, M. A., Wells, A. L., Sweeney, H. L., & Wilson, J. M. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.15-1907 · Cited by 146
Kaplan, J. M., Armentano, D., Sparer, T. E., Wynn, S. G., Peterson, P. A., Wadsworth, S. C., Couture, K. K., Pennington, S. E., George, J. A. S., Gooding, L. R., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-45 · Cited by 103
Lochmüller, H., Petrof, B., Pari, G., Larochelle, N., Dodelet, V., Wang, Q., Allen, C. A., Prescott, S. M., Bernard Massie, B., Nalbantoglu, J. N., et al. (1996) · PubMed · Cited by 102
Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre
Chen, L., Anton, M., & Graham, F. L. (1996) · Somatic Cell and Molecular Genetics · doi:10.1007/bf02369439 · Cited by 100
Self-citationImmune Responses to Adenoviral Vectors During Gene Transfer in the Brain
Kajiwara, K., Byrnes, A. P., Charlton, H. M., Wood, M. J. A., & Wood, K. J. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.3-253 · Cited by 90
Gahéry‐Ségard, H., Juillard, V., Gaston, J., Lengagne, R., Pavirani, A., Boulanger, P. A., & Guillet, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270312 · Cited by 72
Sykes, R. C., Lin, D., Hwang, S., Framson, P. E., & Chinault, A. C. (1988) · Molecular and General Genetics MGG · doi:10.1007/bf00334700 · Cited by 70
Morsy, M., Zhao, J. Z., Ngo, T. T., Warman, A. W., O’Brien, W. E., Graham, F. L., & Caskey, C. T. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118482 · Cited by 29
Self-citation
Cited by
GENE THERAPY: Twenty-First Century Medicine
Verma, I. M., & Weitzman, M. D. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 616
Update on adenovirus and its vectors
Russell, W. C. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2573 · Cited by 596
Morral, N., O’Neal, W., Rice, K., Leland, M., Kaplan, J., Piedra, P. A., Zhou, H., Parks, R. J., Velji, R., Aguilar-Córdova, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12816 · Cited by 409
Self-citationAdenovirus vectors for gene delivery
Benihoud, K., Yeh, P., & Perricaudet, M. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00007-5 · Cited by 350
Viral gene therapy strategies: from basic science to clinical application
Young, L. S., Searle, P. F., Onion, D., & Mautner, V. (2006) · The Journal of Pathology · doi:10.1002/path.1896 · Cited by 313
Metadata
- Authors
- Morsy, M. A., Gu, M., Motzel, S., Zhao, J., Lin, J., Su, Q., Allen, H., Franlin, L., Parks, R. J., Graham, F. L., Kochanek, S., Bett, A. J., & Caskey, C. T.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-07-07
- Volume
- 95
- Issue
- 14
- Pages
- 7866-7871
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2114445152
- Cited by
- 365
- References
- 34
- FWCI
- 24.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.